Nara et al. reported that the serum IL–6 level was 9 pg/ml or higher in all 6 patients with CADM-IP who died of IP, whereas it was lower than 9 ng/ml in 5 of 6 survivors [39]. Here, IL6 is linked to clinically amyopathic dermatomyositis.